INTRODUCTION
Calcium and sodium spirulans (Ca-SP and Na-SP, respectively) are novel sulfated polysaccharides isolated from a hot water extract of the blue-green alga Spirulina platensis. 1, 2) Structural analysis of Ca-SP indicated that the polysaccharide is composed of rhamnose, 3-O-methylrhamnose (acofriose), 2,3-di-O-methylrhamnose, 3-O-methylxylose, uronic acids and sulfate, and the backbone consists of 1,3-linked rhamnose and 1,2-linked 3-O-methylrhamnose units with some sulfate substitution at the 4-position; the polymer is terminated at the nonreducing end by 2,3-di-O-methylrhamnose and 3-O-methylxylose residues. 3) Recently, it was confirmed that Ca-SP contains two types of disaccharide repeating units, Ohexuronosyl-rhamnose (aldobiuronic acid) and Orhamnosyl-acofriose with sulfated groups. 4) Ca-SP and Na-SP exhibit antithrombin activity by activation of heparin cofactor II 5) which is a physiological inhibitor of thrombin, in a different mechanism from that of heparin. 6) In addition to the direct action to heparin cofactor II, Ca-SP and Na-SP stimulate the synthesis of tissue plasminogen activator but not plasminogen activator inhibitor type 1 in human fetal lung fibroblasts, 7) suggesting that the polysaccharides may enhance the fibrinolytic activity in the blood. However, it has been unclear whether Ca-SP and Na-SP can modulate the antithrombogenic activity of vascular endothelial cells. 8) (which has a potent preventative activity against platelet aggregation) and tissue plasminogen activator 9) (which converts plasminogen to plasmin that degrades fibrin). Proteoglycans are macromolecules which are composed of a core protein and one or more glycosaminoglycan side chains as a common feature. Vascular endothelial cells synthesize and secrete a large heparan sulfate proteoglycan (HSPG) perlecan and a small chondroitin/dermatan sulfate proteoglycan (CS/DS PG) biglycan. 10) Perlecan and biglycan exhibit an antithrombin activity by activation of antithrombin III and heparin cofactor II, respectively. 11, 12) Metabolism of proteoglycans has been implicated in the modulation of endothelial cell functions such as proliferation 13) as well as abnormal behavior of vascular smooth muscle cells. 14) Recently, we found that Ca-SP inhibits the repair of wounded monolayers of vascular endothelial cells through inhibition of the proliferation, 15) indicating that Ca-SP may influence the metabolism of proteoglycans in the cells. The present study was undertaken to clarify the alteration of proteoglycan metabolism by Ca-SP and Na-SP as anticoagulant agents in vascular endothelial cells using a cell culture system of the cells.
MATERIALS AND METHODS
Materials ---Vascular endothelial cells from bovine aorta were purchased from Dainippon Pharmaceutical (Osaka, Japan). Dulbecco's modified Eagle's medium (DMEM) and bovine fetal serum were from Nissui Pharmaceutical (Tokyo, Japan) and EquitechBio (Kerrville, TX, U.S.A.), respectively. ASF 301 medium was from Ajinomoto (Tokyo, Japan). Tissue culture plates and dishes were obtained from Iwaki Glass (Chiba, Japan). DEAE-Sephacel, benzamidine, Tris base and phenylmethanesulfonyl fluoride were from Sigma. [ 35 S]NaSO 4 (carrier free) was purchased from ICN Biomedicals (Irvine, CA, U.S.A.). Cetylpyridinium chloride (CPC) and other reagents were from Nacalai Tesque (Kyoto, Japan).
Incorporation of [
35 S]Sulfate into Proteoglycans ---Vascular endothelial cells were cultured in DMEM supplemented with 10% fetal bovine serum in 24-well culture plates or 100-mm dishes at 37°C in 5% CO 2 in air until confluent. The medium was discarded and the cell layer was washed twice with serum-free ASF 301 medium, then incubated at 37°C for 24 hr in fresh serum-free ASF 301 medium with Ca-SP or Na-SP (10, 20, 30, 40 or 50 µg/ml) in the presence of [
35 S]sulfate (1 MBq/ml). After incubation, the conditioned medium was harvested and solid urea was added to a concentration of 8 M. The cell layer was washed twice with ice-cold Ca, Mg-free phosphate-buffered saline and extracted with 8 M urea solution containing 0.1 M 6-aminohexanoic acid, 5 mM benzamidine, 10 mM N-ethylmaleimide, 2 mM EDTA, 0.1 M phenylmethanesulfonyl fluoride, 0.1 M NaCl, 50 mM Tris base and 2% Triton X-100 (pH 7.5) at 4°C for 15 min and the cell layer extract was harvested by scraping with a rubber policeman. The incorporation of [
35 S]sulfate into proteoglycans was determined by the CPC precipitation method. 16) Briefly, portions of the medium and cell layer extracts were spotted on filter papers and washed five times for 1 hr in 1% CPC with 0.05 M NaCl. The radioactivity of precipitated proteoglycans on the dried filter paper was measured by liquid scintillation counting. 35 S]sulfate-labeled proteoglycans from the cell layer treated with Na-SP (10 µg/ml) for 3 hr were separated into HSPGs and CS/DS PGs on the basis of differences in charge density by DEAE-Sephacel ion exchange chromatography. The proteoglycans extracted from the conditioned medium were applied to DEAE-Sephacel (5 ml of resin) in 8 M urea buffer (pH 7.5) containing 2 mM EDTA, 0.25 M NaCl, 0.5% Triton X-100, and 50 mM Tris base. Unbound radioactivity was removed from the column by washing with 30 ml of the buffer. Bound radioactivity was eluted from the column with a linear gradient of 0.25-0.7 M NaCl in the urea buffer (total volume of 50 ml); in this chromatography, HSPGs and CS/ DS PGs were eluted at ~0.45 M and 0.55 M NaCl, respectively.
10)
Statistical Analysis ---Data on the accumulation and release of [
35 S]sulfate-labeled proteoglycans were analyzed for statistical significance by ANOVA. p Values of less than 0.05 were considered to indicate statistically significant differences.
RESULTS

Figure 1 shows the accumulation of [
35 S]sulfatelabeled proteoglycans in the cell layer and the conditioned medium of vascular endothelial cells after treatment with Ca-SP. As shown, the accumulation in the cell layer was significantly decreased whereas that in the conditioned medium was increased by Ca-SP in a dose-dependent manner. A similar result was obtained when the cells were treated with Na-SP. These results indicated that Ca-SP and Na-SP inhibit the association of proteoglycans newly synthesized by vascular endothelial cells with the cell layer.
To examine the possibility that Ca-SP and Na-SP stimulate the release of proteoglycans associated with the vascular endothelial cell layer, the cells prelabeled with [
35 S]sulfate were treated with Ca-SP and the release of proteoglycans was determined. As shown in Fig. 2 , the proteoglycan release was significantly increased by Ca-SP in a dose-dependent manner, indicating that Ca-SP not only inhibits the association of newly synthesized proteoglycans with the cell layer but also stimulates the release of cell-associated proteoglycans to the liquid phase. Na-SP also stimulates the release of proteoglycans from endothelial cell layers in a fashion equal to that of Ca-SP (not shown). Figure 3 shows the DEAE-Sephacel profiles of [ 35 S]sulfate-labeled proteoglycans released from the cell layers of vascular endothelial cells treated with or without Na-SP. It was shown that Na-SP stimulates the release of both HSPGs and CS/DS PGs from the cell layer. 
DISCUSSION
In the present study, Ca-SP and Na-SP were found to inhibit the association of proteoglycans with vascular endothelial cells; as the result, release of cell-associated proteoglycans was also promoted by the polysaccharides. It was shown earlier that heparin is a unique sulfated polysaccharide that stimulates the release of proteoglycans from the vascular endothelial cell layer. 17) Other polysaccharides including heparan sulfate, chondroitin sulfate, dermatan sulfate and hyaluronan as well as low molecular weight heparin do not exhibit such a stimulatory activity, 17) suggesting that stimulation of endothelial proteoglycan release is not a general effect of (sulfated) polysaccharide. Thus, it is indicated that Ca-SP and Na-SP are also unique sulfated polysaccharides that accelerate endothelial proteoglycan release like heparin. Since heparin is postulated to exhibit the antithrombin activity not only by activating antithrombin III and heparin cofactor II in the blood but also by stimulating the release of anticoagulant heparan sulfate on the surface of the vascular endothelium, it is likely that Ca-SP and Na-SP also may exhibit antithrombin activity by a similar mechanism in the blood.
Proteoglycans synthesized and secreted by vascular endothelial cells are involved in the regulation of functions of the cells. For example, heparan sulfate chains of perlecan promote the binding of basic fibroblast growth factor, which stimulates the proliferation of the cells as an autocrine 18) to the receptor. 19) On the other hand, the core protein of biglycan binds transforming growth factor-β, which inhibits endothelial cell proliferation, 20) and sequesters the cytokine from the cell surface receptor. 21) Since it was suggested that Ca-SP and Na-SP inhibit the association of both HSPGs and CS/DS PGs, resulting in a decrease in both types of newly synthesized proteoglycans in endothelial cell layers, the polysaccharides may influence the regulation of function of the cells by basic fibroblast growth factor and transforming growth factor-β. In fact, we have shown that Ca-SP inhibits the proliferation of vascular endothelial cells by inducing a lower ability to respond to stimulation by endogenous basic fibroblast growth factor. 15) Although it has been reported that endothelial proteoglycan synthesis is modulated by several factors including transforming growth factor-β 1 , 10) interleukin-1β 22) and tumor necrosis factor-α, 23) little is known about the regulation of the secretion. It was suggested that activation of protein kinase C stimulates the release of either HSPGs and CS/DS PGs from cultured vascular endothelial cells. 24) Thus, although it is possible that Ca-SP and Na-SP physicochemically compete with HSPGs and CS/ DS PGs at their binding sites to other components of extracellular matrix in endothelial cells, it is also possible for the polysaccharides to influence the intracellular signal transduction such as protein kinase C by stimulation of some receptors. However, this remains to be confirmed.
In conclusion, it was found that novel sulfated polysaccharides from Spilurina platensis Ca-SP and Na-SP inhibit the association of HSPGs and CS/DS PGs with vascular endothelial cell layers. It is suggested that either Ca-SP or Na-SP influences the functions of vascular endothelial cells regulated by autocrine and paracrine mediators such as basic fibroblast growth factor through alteration of the proteoglycan metabolism. Further studies are nec- essary to clarify whether or not Ca-SP and Na-SP have beneficial effects as anticoagulant agents on the blood coagulation-fibrinolytic system through not only activation of heparin cofactor II but also influence upon vascular endothelial cell function.
